Related Experiment Video
Updated: May 6, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Deficiency of protein C in congenital thrombotic disease
Insights
This study identified an inherited deficiency in protein C, a key plasma protein, as the cause of recurrent thrombosis in a family. Lower protein C levels were observed in affected individuals, suggesting a genetic link to blood clotting disorders.
Area of Science:
- Biochemistry
- Genetics
- Hematology
Background:
- Recurrent thrombosis poses a significant health risk.
- Investigating genetic factors for thrombotic disorders is crucial.
- Plasma protein deficiencies can predispose individuals to clotting.
Observation:
- A family presented with a history of recurring thrombosis.
- Protein C antigen levels were measured using the Laurell rocket technique.
- Severely affected members showed 38-49% of normal protein C levels, while unaffected members had normal levels.
Findings:
- A significant deficiency in protein C antigen was identified in affected family members.
- No familial deficiency was found for antithrombin III or plasminogen.
- The observed protein C deficiency correlated with the incidence of thrombosis within the family.
Implications:
- Inherited protein C deficiency is a likely cause of recurrent thrombosis in this family.
- Understanding protein C's role in coagulation is vital for managing thrombotic risks.
- Genetic screening for protein C deficiency may aid in predicting and preventing thrombotic events.
Abstract:
A family with a history of recurring thrombosis was studied to determine if a plasma protein deficiency could account for the observed disease. Protein C levels in plasma were determined immunologically using the Laurell rocket technique. The propositus, his father, and his paternal uncle, who are severely affected, had 38-49% of normal levels of protein C antigen, whereas unaffected family members had normal levels. There was no familial deficiency of antithrombin III and plasminogen. Because activated protein C is a potent in vitro anticoagulant enzyme and an in vivo profibrinolytic agent, it is suggested that the recurrent thrombotic disease in this family is due to an inherited deficiency in protein C.
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Inborn Errors of Metabolism
Cytomegalovirus Disease

